{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-025257","form_type":"8-K","ticker":"ASBP","cik":"0001847345","company_name":"Aspire Biopharma Holdings, Inc.","filed_at":"2025-08-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.333786+00:00","generated_at":"2026-05-17T10:38:11.108071+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Aspire Biopharma raises $7.75M via convertible notes with 20% OID, maturity Feb 2026","bullets":["Aggregate principal $9.6875M issued at $7.75M subscription price (20% OID) for three tranches.","Notes mature Feb 19, 2026; convertible at 80% of lowest closing price in prior 5 trading days.","Proceeds to pay off debt and for working capital; RBW Capital Partners received 8% commission.","Registration rights agreement requires resale registration statement filed by Sept 18, 2025.","Company may prepay at 20% premium; conversion capped at 4.99% (or 9.99%) beneficial ownership."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-025257","json":"https://secwatch.observer/filing/0001641172-25-025257.json","markdown":"https://secwatch.observer/filing/0001641172-25-025257.md","text":"https://secwatch.observer/filing/0001641172-25-025257.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847345/000164117225025257/0001641172-25-025257-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847345/000164117225025257/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T10:38:11.108071+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}